Anti-Toll-like receptor 2 antibody inhibits nuclear factor kappa B activation and attenuates cardiac damage in high-fat-feeding rats

Acta Biochim Biophys Sin (Shanghai). 2019 Apr 1;51(4):347-355. doi: 10.1093/abbs/gmz009.

Abstract

Long-time consumption of high-fat food is a direct cause of cardiovascular diseases, and high-fat-related inflammation plays an important role in it. Toll-like receptors (TLRs), especially TLR2 and TLR4, play important roles in high-fat-related inflammation. However, the impact of TLR2 on high-fat-associated cardiovascular complications is still unknown. In this study, we try to investigate the relationship between TLR2 and high-fat-related cardiac injury. SD rats were allocated to either a control group which were fed with normal diet or a high-fat group which were fed with high-fat diet for 5 months. At the last month, rats fed with high-fat diet were intraperitoneally injected with control normal mouse IgG or anti-TLR2 antibody. Heart tissues were collected for further analysis. RT-qPCR and western blot analysis results revealed that TLR2 expression was increased in the heart tissues from rats fed with high-fat diet and anti-TLR2 antibody had no effect on TLR2 expression. However, anti-TLR2 antibody alleviated masson staining area, levels of TGF-β1 and Collagen I mRNA, and decreased TUNEL-positive myocardial cells and caspase-3 activity, suggesting that anti-TLR2 antibody protected cardiac cells against high-fat-induced cardiac fibrosis and cell apoptosis. By using immunohistochemistry, RT-qPCR and ELISA, we found that anti-TLR2 antibody blocked NF-κB activation, inhibited the expression of inflammatory factors such as TNF-α, IL-1β, IL-6 and IL-18 in the heart tissues from rats fed with high-fat diet. These results hinted that anti-TLR2 antibody might exert its protective effect via inhibition of the TLR2/NF-κB/inflammation pathway. Our findings suggest that anti-TLR2 antibody has a preventive function against high-fat-induced deleterious effects in the heart, and anti-TLR2 antibody may be used as an attractive therapeutic option for high-fat-induced cardiac injury.

Keywords: NF-κB; TLR2; anti-TLR2 antibody; heart injury; high-fat.

MeSH terms

  • Animals
  • Antibodies / immunology
  • Antibodies / pharmacology*
  • Apoptosis / drug effects
  • Apoptosis / genetics
  • Cardiomyopathies / etiology
  • Cardiomyopathies / metabolism
  • Cardiomyopathies / prevention & control*
  • Collagen Type I / genetics
  • Collagen Type I / metabolism
  • Cytokines / genetics
  • Cytokines / metabolism
  • Diet, High-Fat / adverse effects
  • Female
  • Gene Expression Regulation / drug effects
  • Inflammation Mediators / metabolism
  • Male
  • Mice, Inbred BALB C
  • NF-kappa B / antagonists & inhibitors*
  • NF-kappa B / genetics
  • NF-kappa B / metabolism
  • Rats, Sprague-Dawley
  • Toll-Like Receptor 2 / genetics*
  • Toll-Like Receptor 2 / immunology
  • Toll-Like Receptor 2 / metabolism
  • Transforming Growth Factor beta1 / genetics
  • Transforming Growth Factor beta1 / metabolism

Substances

  • Antibodies
  • Collagen Type I
  • Cytokines
  • Inflammation Mediators
  • NF-kappa B
  • Toll-Like Receptor 2
  • Transforming Growth Factor beta1